Inspect-IR Systems, Inc.
Inspect-IR Systems, Inc.
InspectIR Systems is a leader in breath-based diagnostics. Through the use of portable mass spectrometry, InspectIR can determine the chemistry and biomarkers present in the breath. This capability allows for screening and early detection of several diseases, the presence of illicit drugs, or overall health and wellness.
With that same rigor and portable analytical capability, InspectIR Systems is also looking at environmental compounds in near real-time. The ability to characterize and quantify compounds allows for several use-cases, including: illicit drug detection, chemical weapons and explosives detection, and petrochemical or agrochemical pollution. Ruggedized instrumentation allows for fast and accurate in-field testing with impacts on health and safety.
Subject Exhales through their mouth into a tube connected to a test kit, much like blowing up a balloon.
Chemistry in the subject’s breath is captured on the patented inspector systems device.
Patent issued measurement process runs, allowing identify- cation & qualification of COVID-19 markers & spectrometry.
Inspect-ir systems device analyzes and displays results utilizing proprietary software.
The InspectIR PNY-1000 is a first-of-its-kind device that utilizes a mini mass spectrometer and our other patented components to deliver lab results in the field.
By analyzing samples by their chemical fingerprint, we are able to look for the presence of chemicals in breath/air that allow us to determine if the disease or substance of interest is present in a sample.
Currently we are using our technology and pairing it with machine learning to expand the range of substances and diseases we can detect in a breath sample.
The InspectIR PNY-1000 is a first-of-its-kind device that utilizes a mini mass spectrometer and our other patented components to deliver lab results in the field.
By analyzing samples by their chemical fingerprint, we are able to look for the presence of chemicals in breath/air that allow us to determine if the disease or substance of interest is present in a sample.
Currently we are using our technology and pairing it with machine learning to expand the range of substances and diseases we can detect in a breath sample.
